Course Overview
Clinical management of chronic cardiovascular disease is a key component of the work of advanced practice nurses and registered nurses in cardiology and primary care settings. PCNA develops an annual CE program to meet the clinical practice and recertification needs of these clinicians.
This 2022 curriculum includes a comprehensive approach to cardiovascular risk assessment and treatment in:
- Assessing Cardiovascular Risk: Where Are the Data Now and Where Do We Go From Here?
- Kidney Disease and Cardiovascular Health: Implications for Treatment
- Complex Cases in Lipid Management: Treating LDL and Beyond
- Resistant Hypertension: Who is at risk? Detection, Evaluation, and Treatment
- COVID-19 Long-Haulers: The search for answers
- Management of Atrial Fibrillation, from A to Z
- Maternal Mortality, Cardiovascular Disease, and Prevention
- Essential Skills for Today’s Nurse Leaders: Making an Impact with Social Media
Member Cost: $35Non-member Cost: $75
Credits: 10.55 CE contact hours, 1.35 CE pharmacology hours
Learning Objectives
- Assessing Cardiovascular Risk: Where Are the Data Now and Where Do We Go From Here?
- Explain the role of CV risk assessment as part of guidelines-directed therapy.
- Discuss health disparities associated with CV risk assessment.
- Describe risk-enhancing factors to take into consideration and when to consider screening for elevated Lp (a) and Coronary Artery Calcium (CAC) score
- Review any emerging CV risk assessment techniques that may compliment the current model of risk assessment.
- Kidney Disease and Cardiovascular Health: Implications for Treatment
- Describe the relationship between the renal system and cardiovascular system and the link between CKD and CVD.
- Explain the importance of monitoring renal function in patients with CVD, when to be alarmed, and indications for referral.
- Review current data on SGLT2i outcome trials in reduction of cardiovascular risk and renal disease progression in patients with and without DM2.
- Complex Cases in Lipid Management: Treating LDL and Beyond
- Identify at-risk populations with hypercholesterolemia including FH/FHoH.
- Summarize pharmacologic and non-pharmacologic approaches to lowering cholesterol and triglycerides.
- Using case studies, select the appropriate cholesterol-lowering pharmacologic agent for specific patients including statins and moving into novel therapies.
- Collaborate for solutions to close the gap across race and ethnicity in the application of evidence-based cholesterol-lowering guidelines.
- Resistant Hypertension: Who is at risk? Detection, Evaluation, and Treatment
- Define resistant hypertension and its prevalence in the population.
- Explain the common steps in the detection and evaluation of resistant hypertension.
- Describe accepted approaches to the management of resistant hypertension.
- Review the importance of patient involvement and shared decision-making in the management of resistant hypertension and associated co-morbid conditions including medication regimen.
- COVID-19 Long-Haulers: The search for answers
- Review COVID-19 and adverse physical manifestations in the post-acute phase.
- Explain data on chronic COVID syndrome (CCS) or long-hauler syndrome, and the persistent physical manifestations.
- Identify the possible long-term cardiovascular risks in patients with a history of COVID-19 infection and necessary screening and assessment techniques.
- Review gaps and opportunities for further research in regards to COVID-19 long-hauler syndrome.
- Management of Atrial Fibrillation, from A to Z
- Identify the available pharmacologic therapies for the management of Atrial Fibrillation for rate and rhythm control.
- Review the non-pharmacologic treatment options for Atrial Fibrillation, including cardioversion, surgery, and catheter ablation.
- Explain key strategies in decision-making for the management of Atrial Fibrillation.
- Describe the role of consumer wearables in the continued monitoring of patients being treated for Atrial Fibrillation.
- Maternal Mortality, Cardiovascular Disease, and Prevention
- Review the burden of CVD on maternal mortality and its important role.
- List maternal risk factors and the importance of early identification and prevention of CVD.
- Identify health disparities related to maternal mortality, especially as it relates to access to care as well as racial and socioeconomic inequalities.
- Explain a team-based approach and the nurse navigator's role in reducing the risk of CVD in women of childbearing age.
- Essential Skills for Today's Nurse Leaders: Making an Impact with Social Media
- Review the essential qualities and skill sets associated with leadership in nursing.
- Define social media and review the various platforms commonly used
- Explain the development and value of nursing leadership in social media for both formal and informal leadership positions.
- Discuss how nurse leaders leverage social media to develop digital leadership and visibility and become role models.
Faculty
- Donald Lloyd-Jones, MD, ScM, FACC, FAHA
- Rajesh Mohandas, MD, MPH
- Susan Halli-Demeter, DNP, CNP, FNP-BC
- Vivek Bhalla, MD
- Dr. Amanda Verma
- Bill Miles, MD, FACC
- Erin Ferranti, PhD, MPH, RN, FAHA
- Lynne Braun, PhD, CNP, CLS, FAHA, FPCNA
This activity has been planned and implemented in accordance with the Accreditation Standards of the American Association of Nurse Practitioners® (AANP) through the joint providership of PCNA. PCNA is accredited by AANP as an approved provider of nurse practitioner continuing education. Provider number: 030602.